Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-26 @ 3:56 AM
Study NCT ID:
NCT06144918
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2023-11-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure
Sponsor:
Skye Bioscience, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2023-11-14
First Submit QC Date:
None
Study First Post Date:
2023-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-13
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL